Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness

Piero L. Olliaro; Michel Vaillant

doi:10.1371/journal.pmed.1002850

Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness

Piero L. Olliaro^*, Michel Vaillant

^*Corresponding author for this work

Competence Center for Methodology and Statistics

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Original language	English
Article number	e1002850
Journal	PLoS Medicine
Volume	16
Issue number	7
DOIs	https://doi.org/10.1371/journal.pmed.1002850
Publication status	Published - Jul 2019

Access to Document

10.1371/journal.pmed.1002850

Cite this

@article{847415d88db744ea981387f4269e82b5,

title = "Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness",

author = "Olliaro, {Piero L.} and Michel Vaillant",

note = "Funding Information: The authors received no specific funding for this work. PLO was also a staff member of the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland, at the time of the writing of this paper. MV is a staff member of LIH. The opinions expressed are those of the authors and do not necessarily represent the views and opinions of their employers.",

year = "2019",

month = jul,

doi = "10.1371/journal.pmed.1002850",

language = "English",

volume = "16",

journal = "PLoS Medicine",

issn = "1549-1277",

publisher = "Public Library of Science",

number = "7",

}

TY - JOUR

T1 - Designing noninferiority tuberculosis treatment trials

T2 - Identifying practical advantages for drug regimens with acceptable effectiveness

AU - Olliaro, Piero L.

AU - Vaillant, Michel

N1 - Funding Information: The authors received no specific funding for this work. PLO was also a staff member of the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland, at the time of the writing of this paper. MV is a staff member of LIH. The opinions expressed are those of the authors and do not necessarily represent the views and opinions of their employers.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85069858094&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1002850

DO - 10.1371/journal.pmed.1002850

M3 - Review article

C2 - 31299047

AN - SCOPUS:85069858094

SN - 1549-1277

VL - 16

JO - PLoS Medicine

JF - PLoS Medicine

IS - 7

M1 - e1002850

ER -

Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness

Access to Document

Other files and links

Cite this